Latest Regulatory News

CVC Limited is contemplating a fresh offer of Capital Notes, potentially including a reinvestment option for existing holders, contingent on market and regulatory conditions.

Neurizon Therapeutics has secured FDA clearance to resume clinical trials for its lead ALS drug NUZ-001, alongside a $5.2 million capital raise and a key licensing deal with Elanco Animal Health. These developments position the company for a critical growth phase in neurodegenerative disease therapeutics.

Challenger Limited has welcomed APRA’s proposed capital standards for longevity products, highlighting their potential to reduce capital requirements and stimulate growth in Australia’s retirement income sector.

FIN Resources Limited has executed a binding agreement to acquire the fully permitted, high-grade Cabin Lake Gold Project in Canada’s Northwest Territories, setting the stage for immediate exploration and resource growth.

BlinkLab has completed its U.S. autism pilot study with strong diagnostic accuracy and expanded its pivotal FDA trial to seven leading research centers, positioning itself for regulatory submission in late 2026.

Southern Palladium Limited has launched a Share Purchase Plan allowing eligible shareholders to invest up to $30,000 at $1.10 per share, aiming to raise $1 million to advance its Bengwenyama mine project in South Africa.

Strategic Energy Resources has advanced its copper-gold exploration in Queensland through government-backed drilling, a $3 million joint venture program, and a key acquisition from Anglo American, supported by a $2 million capital raise.

Cue Energy Resources reported steady production with notable gains at Mahato and Maari fields, alongside a new gas supply deal and a $3.5 million dividend payment.

CuFe Ltd has announced a dramatic 400% increase in contained copper at its Gecko project, alongside an upgraded Orlando resource and a $5.4 million capital raise to advance its Tennant Creek development plans.

Star Minerals has raised $1.5 million through a share placement to fund critical drilling and mining approvals at its Tumblegum South Gold Project, aiming for production start in early 2026.

Locate Technologies reported steady Q1 FY26 revenue with a strategic pivot to the NZX to better support its Bitcoin treasury ambitions. The company’s Locate2u unit showed promising growth, while Zoom2u faced challenges amid softer consumer spending.

Locate Technologies reports a 19% revenue increase in its Locate2u segment and progresses toward a December 2025 NZX listing, supported by new board appointments and a NZD 10 million ATM facility.